BioDelivery Sciences International Inc. (BDSI): CFO James A. McNulty Sold 108,798 Shares
CFO James A. McNulty sold 108,798 shares of BDSI stock on 07/06/2012 at the average price of $5. James A. McNulty owns at least 43,159 shares after this. The price of the stock has decreased by 3.8% since.
BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. Biodelivery Sciences International Inc. has a market cap of $144.7 million; its shares were traded at around $4.81 with a P/E ratio of 20.3 and P/S ratio of 44.4.
Director William B. Stone and Director John J. Shea both also sold shares of BDSI stock.
LinkedIn Corporation (LNKD): Senior Vice President and CFO Steven J. Sordello Sold 44,600 Shares
Senior Vice President and CFO Steven J. Sordello sold 44,600 shares of LNKD stock on 07/09/2012 at the average price of $103.54. Steven J. Sordello owns at least 45,317 shares after this. The price of the stock has decreased by 0.28% since.
LinkedIn Corporation is an online professional network which allows members to create, manage, and share their professional identity online, build and engage with their professional network, access shared knowledge and insights, and find business opportunities. LinkedIn Corporation has a market cap of $10.91 billion; its shares were traded at around $103.25 with a P/E ratio of 703.9 and P/S ratio of 20.9.
LinkedIn Corporation has released its first quarter 2012 results ended March 31, 2012. For this quarter, the company generated revenues of $188.5 million – an increase of 101% compared to $93.9 million in the same quarter last year. GAAP Net income was $5.0 million, compared to $2.1 million last year.
Multiple other insiders also recently sold shares of LNKD stock.
Verisk Analytics Inc. (VRSK): Executive Vice President and CFO Mark V. Anquillare Sold 40,000 Shares
Executive Vice President and CFO Mark V. Anquillare sold 40,000 shares of VRSK stock on 07/10/2012 at the average price of $49.71. Mark V. Anquillare owns at least 21,408 shares after this. The price of the stock has increased by 0.6% since.
Verisk Analytics is a provider of risk assessment solutions to professionals in insurance, healthcare, mortgage lending, government, risk management, and human resources. Verisk Analytics Inc. has a market cap of $8.41 billion; its shares were traded at around $50.01 with a P/E ratio of 27.7 and P/S ratio of 6.3.
Verisk Analytics Inc. reported first quarter 2012 net income of $74.6 million. Diluted GAAP EPS was $0.44 for this quarter, and total revenue increased 10.7% over prior year quarter. EBITDA increased 15% to $159.2 million for this quarter.
ABIOMED Inc. (ABMD): CFO Robert Bowen Sold 16,715 Shares
CFO Robert Bowen sold 16,715 shares of ABMD stock on 07/13/2012 at the average price of $24.26. Robert Bowen owns at least 61,334 shares after this. The price of the stock has decreased by 0% since.
Abiomed Inc. is a developer, manufacturer and marketer of medical products designed to safely and effectively assist or replace the pumping function of the failing heart. Abiomed Inc. has a market cap of $962.5 million; its shares were traded at around $24.26 with a P/E ratio of 488.8 and P/S ratio of 7.6.
Abiomed Inc. has released its fourth quarter 2012 earnings results. The company reported fourth quarter revenues of $37.3 million – up 31% over prior year’s revenues of $28.5 million. GAAP net income was $2.6 million ($0.06 per share), compared to net loss of $1.8 million ($0.05 per share) prior year quarter.
Argan Inc. (AGX): Senior Vice President and CFO Arthur F. Trudel Sold 12,090 Shares
Senior Vice President and CFO Arthur F. Trudel sold 12,090 shares of AGX stock on 07/10/2012 at the average price of $13.61. Arthur F. Trudel owns at least 27,000 shares after this. The price of the stock has increased by 14.99% since.
Argan Inc., headquartered in Rockville, Md., through its wholly owned Southern Maryland Cable Inc. Argan Inc. has a market cap of $211.3 million; its shares were traded at around $15.65 with a P/E ratio of 18.2 and P/S ratio of 1.5. Argan Inc. had an annual average earnings growth of 15.2% over the past five years.
Argan Inc. recently released its first quarter 2012 results ended April 30, 2012. During this quarter, the company generated revenues of $63.7 million compared to $16.0 million prior year quarter. Net income was $4.4 million ($0.32 per share), and Argan reported EBITDA of $7.3 million for this quarter.
For the complete list of stocks that Sold by their CFOs, go to: Insider Buys.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.